Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial — BIO|Sync-HUTT

Syncope Clinical Trial

Official title:
BIO|Sync-HUTT: Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial

Status Completed

Clinical Trial Summary

The purpose of this study is to explore changes in patients' hemodynamic parameters during the Head-Up Tilt Test ("HUTT") and their timing with respect to onset of the Closed Loop Stimulation (CLS) pacing. This study aims to add knowledge to better understand the mechanisms underlying recurrent syncopal events and optimal pacing programming.

Clinical Trial Description

The 2021 European Society of Cardiology guidelines recommend cardiac pacing in patients aged >40 years with tilt-induced asystolic reflex syncope (class I, level of evidence A). The recommendation relies on recent results from the multicentre, randomised, double-blinded, parallel-design BIOSync trial (NCT02324920). The BIOSync study provided evidence of benefit of dual chamber pacing in patients with tilt-induced reflex syncope and confirmed the role of Head-up Tilt Table (HUTT) test as a diagnostic method for cardiac pacing in reflex syncope. The Closed Loop Stimulation (CLS) is able to measure changes in intracardiac impedance during the systolic phase of each cardiac cycle which are strictly correlated to the increased heart rate and right ventricular contraction speed which are usually present during the pre-syncope phase of the reflex. It was hypothesized that an early onset of CLS pacing may be triggered by the compensatory increase in heart rate to counteract vasodilation and pressure drop during the pre-syncope phase of the reflex. The BIOSync study showed a 77% reduced risk of syncope in the DDD-CLS group as compared to pacing off. The design of the BIOSync study did not allow to assess the specific effect that CLS adds to dual-chamber pacing. Despite DDD-CLS pacing, 22% of patients had syncopal recurrence in 2 years. Further investigations are therefore needed in order to reduce this failure rate. Indeed, it is still unclear whether syncopal recurrences should be ascribed to dominant vasodilation or if the CLS programming/functioning needs optimization to more adequately sustain cardiac output during reflex in these specific cases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06038708
Study type	Observational [Patient Registry]
Source	Biotronik SE & Co. KG
Contact
Status	Completed
Phase
Start date	September 29, 2022
Completion date	May 12, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00069693` - Evaluation of Chronic Orthostatic Intolerance	N/A
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Completed	`NCT02565238` - BIO.MASTER.BioMonitor 2 Study	N/A
Active, not recruiting	`NCT01965899` - Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System	N/A
Completed	`NCT00746564` - Study of New Implantable Loop Recorder	N/A
Completed	`NCT00359203` - ISSUE3: International Study on Syncope of Uncertain Etiology 3	Phase 4
Recruiting	`NCT04972071` - SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations	N/A
Completed	`NCT04198220` - BIO\|STREAM.ICM Obesity
Recruiting	`NCT04533425` - Practical Approaches to Care in Emergency Syncope
Completed	`NCT05571254` - The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
Recruiting	`NCT05621460` - The Effect of Water Carbonation on Orthostatic Tolerance	N/A
Not yet recruiting	`NCT05957315` - Mobile Cardiac Outpatient Telemetry for Unexplained Syncope	N/A
Recruiting	`NCT04615065` - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed	`NCT05729724` - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Completed	`NCT05782712` - Rapid Measurement of Adenosine in Syncope Patients
Completed	`NCT03786640` - Abbott Brady 3T MRI PMCF
Recruiting	`NCT03803969` - ConfirmRxTM: Posture and Activity	N/A
Recruiting	`NCT05575934` - Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department
Recruiting	`NCT04075084` - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Completed	`NCT02786940` - Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge - A Pilot Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.